US health panel urges restarting J&J COVID-19 vaccinations
U.S. health advisers on Friday urged resuming COVID-19 vaccinations with Johnson & Johnson's single-dose shot, saying its benefits outweigh a rare risk of blood...
How long does protection from COVID-19 vaccines last?
NEW YORK — How long does protection from COVID-19 vaccines last?
Experts don't know yet because they're still studying vaccinated people to see when protection...
New Zealand to consolidate health care into national service
WELLINGTON, New Zealand — New Zealand announced Wednesday it will consolidate its fragmented health care system into a national service similar to the one...
Learning to breathe: Clinic helps COVID long haulers
HEILIGENDAMM, Germany — Simone Ravera rolls up her trousers, slips off her shoes and socks, then gingerly steps into the chilly waters of the...
US weighs next steps for J&J virus shot amid clot mystery
U.S. health officials are weighing next steps as they investigate a handful of unusual blood clots in people who received Johnson & Johnson’s COVID-19...
US recommends ‘pause’ for J&J shots in blow to vaccine drive
WASHINGTON — The U.S. on Tuesday recommended a “pause” in use of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of rare...
This Pathological Life – Allergies Part Two | Anaphylaxis and Fighting Food
In 1901, an experiment when horribly wrong when Doctors attempted to induce tolerance in to a group of dogs by repeated injections of poison....
Tweaked COVID vaccines in testing aim to fend off variants
Dozens of Americans are rolling up their sleeves for a third dose of COVID-19 vaccine -- this time, shots tweaked to guard against a...
EU and COVID-19: When a vaccine only adds to the trouble
BRUSSELS — European Union leaders no longer meet around a common oval summit table to broker their famed compromises. Instead, each of the 27...
UK advises limiting AstraZeneca in under-30s amid clot worry
LONDON — British authorities recommended Wednesday that the AstraZeneca COVID-19 vaccine not be given to adults under 30 where possible because of strengthening evidence...